Abcellera Biologics Inc; Transgenic mice

The contract involves Abcellera Biologics Inc and pertains to the procurement of transgenic mice for the Centers for Disease Control and Prevention (CDC). Announced as a forecast on March 11, 2026, the contract details remain preliminary with no specific solicitation number, NAICS code, or set-aside status provided. The contract aims to support CDC's research and development efforts, likely focusing on advanced biological studies requiring genetically modified animal models. Key points include the involvement of the CDC as the contracting agency, with contact persons listed for program coordination and contracting duties, though the contracting officer has yet to be named. The place of performance and other logistical specifics have not been disclosed. Interested parties seeking further information or engagement are directed to reach out via the provided email contacts or visit the official industry opportunity forecast website.